Malignant Mastocytosis — Trials

Malignant Mastocytosis — Trials · CancerIndex

Clinical trials

Registered studies

14 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 67%
Top sponsor: Cogent Biosciences, Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04996875	(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis	recruiting	Phase 2	140	Cogent Biosciences, Inc.INDUSTRY	14	Sep 15, 2026	clinicaltrials

Data updated 15 days agoSource updated Sep 15, 2026source: clinicaltrials